Bloomberg Anywhere Remote Login Bloomberg Terminal Demo Request


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Bloomberg Customers

February 14, 2016 6:18 PM ET


Company Overview of Acceleron Pharma, Inc.

Key Executives for Acceleron Pharma, Inc.

NameBoard RelationshipsTitleAge
John L. Knopf Ph.D.11 RelationshipsFounder, Chief Executive Officer, President and Director63
Thomas P. Maniatis Ph.D.24 RelationshipsCo-Founder, Chairman of Scientific Advisory Board, Director and Member of Compensation Committee72
Mark Ptashne Ph.D.28 RelationshipsCo-Founder and Member of Scientific Advisory Board--
Kevin F. McLaughlin 9 RelationshipsChief Financial Officer, Senior Vice President and Treasurer59
Steven D. Ertel No RelationshipsChief Operating Officer and Executive Vice President46
View More Key Executives

Acceleron Pharma, Inc. Board Members*

NameBoard RelationshipsPrimary CompanyAge
Francois Nader M.D., M.B.A. 56 RelationshipsNPS Allelix, Corp.58
John L. Knopf Ph.D. 11 RelationshipsAcceleron Pharma, Inc.63
Thomas P. Maniatis Ph.D. 24 RelationshipsAcceleron Pharma, Inc.72
Mark Ptashne Ph.D. 28 RelationshipsAcceleron Pharma, Inc.--
Jean M. George 53 RelationshipsLightstone Ventures57
View All Board Members

Acceleron Pharma, Inc. Executive Committees*

Committee NameChairpersonBoard RelationshipsMembers
Audit Committee Terrence C. Kearney35 Relationships3 Executives
Compensation Committee Joseph S. Zakrzewski103 Relationships3 Executives
Nominating Committee Jean M. George53 Relationships3 Executives
Corporate Governance Committee Jean M. George53 Relationships3 Executives
Advisory Board Ph.D.Thomas P. Maniatis24 Relationships4 Executives
View Committee Details
*Data is at least as current as the most recent Definitive Proxy.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup


  Industry Range
Not meaningful
Total Short Term Compensation$460.0K
Total Value of Options
Compensation as of Fiscal Year
Acceleron Pharma, Inc. CEO Compensation
Industry Average


Wausau Paper Corp. Announces Management Changes
January 22, 2016 8:10 PM ET
Spectrum Brands Holdings, Inc. Appoints David M. Maura as Executive Chairman
January 21, 2016 11:30 AM ET
Peter Harf Intends to Step Down from the Board of Reckitt Benckiser Group plc
December 21, 2015 7:00 AM ET
Blue Power Group Limited Appoints Catherine K. Goodall as Director to the Board
December 05, 2015 12:00 AM ET
Procter & Gamble Co. Announces Executive Changes
November 20, 2015 11:57 PM ET

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Acceleron Pharma, Inc., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at